NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
8.36
-0.15 (-1.76%)
May 13, 2025, 4:00 PM - Market closed
NeoGenomics Employees
NeoGenomics had 2,200 employees as of December 31, 2024. The number of employees increased by 100 or 4.76% compared to the previous year.
Employees
2,200
Change (1Y)
100
Growth (1Y)
4.76%
Revenue / Employee
$305,619
Profits / Employee
-$35,267
Market Cap
1.08B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NEO News
- 13 days ago - NeoGenomics Pays Off 1.25% Convertible Senior Notes - Business Wire
- 13 days ago - NeoGenomics Q1 Earnings: The Stock Price Drop Is A Gift (Rating Upgrade) - Seeking Alpha
- 14 days ago - NeoGenomics, Inc (NEO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 14 days ago - NeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform - PRNewsWire
- 14 days ago - NeoGenomics Reports First Quarter 2025 Results - Business Wire
- 22 days ago - NeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting - Business Wire
- 5 weeks ago - NeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025 - Business Wire
- 5 weeks ago - NeoGenomics Completes Acquisition of Pathline - Business Wire